Market Overview

Akorn Shares Rally Following Increased Price Target

Related AKRX
Earnings Scheduled For May 16, 2016
Mid-Morning Market Update: Markets Edge Higher; Tyson Foods Tops Q2 Estimates
Lannett: Structural Benefits Of The Kremers Acquisition: 100+% Upside (Seeking Alpha)

Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.

The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.

Shares are currently up 5.25 percent at $34.99.

Latest Ratings for AKRX

Mar 2016William BlairMaintainsOutperform
Mar 2016JefferiesMaintainsBuy
Mar 2016SusquehannaMaintainsNeutral

View More Analyst Ratings for AKRX
View the Latest Analyst Ratings

Posted-In: NeedhamAnalyst Color News Price Target Analyst Ratings


Related Articles (AKRX)

View Comments and Join the Discussion!